Journal Articles

The alginogel Flaminal®: an overview of the evidence and use in clinical practice

Share this article

The alginogel Flaminal®: an overview of the evidence and use in clinical practice

Richard White
15 September 2014

The precise positioning of wound care products is an invaluable aid for the clinician, especially where there may be confusion due to the number of similar products. Flaminal® has been positioned as an ‘enzyme alginogel’ by an international panel of experts. In this respect it remains the only product in the category. Careful and accurate positioning is necessary in order that the maximum clinical value can be derived and products used to best effect. The components of Flaminal: alginate, enzymes, and glycol, are designed to provide antimicrobial broad-spectrum action, fluid uptake and moist wound conditions. To best illustrate clinical applications the T.I.M.E. framework is used to guide the clinician. Thus Flaminal may be used, after careful wound assessment, for bioburden control, creation of a moist environment, and promotion of autolytic debridement: a unique combination that will be appropriate for many chronic wounds, and optimal resource use.

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.